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Abstract
Streptomyces strains are well known as promising source of bioactive secondary metabolites, important in ecology, bio-
technology and medicine. In this study, we present the draft genome of the new type strain Streptomyces tunisialbus DSM 
 105760T (= JCM  32165T), a rhizospheric bacterium with antimicrobial activity. The genome is 6,880,753 bp in size (aver-
age GC content, 71.85%) and encodes 5802 protein-coding genes. Preliminary analysis with antiSMASH 5.1.2. reveals 34 
predicted gene clusters for the synthesis of potential secondary metabolites, which was compared with those of Streptomyces 
varsoviensis NRRL ISP-5346.
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Introduction
Since the discovery of streptomycin in 1944 from Streptomy-
ces griseus, the first antibiotic isolated from bacteria (Schatz 
et al. 1944), Actinobacteria have obtained large attention 
from the scientific community, mainly due to their ability 
in producing a wide spectrum of bioactive compounds with 
antimicrobial and antitumor activities (Demain 2014; Barka 
et al. 2016). Nowadays, this class provided more than 65% 
of antibiotics and antifungals used in medicine; including 
over 10,000 bioactive compounds that were produced by 
the members of the genus Streptomyces (Bérdy 2005, 2012; 
De Lima et al. 2012). This genus, proposed for the first time 
by Waksman and Henrici (1943), belong to the Gram-pos-
itive bacteria and is ubiquitous in nature (Kämpfer 2012). 
The classification of Streptomyces species is generally car-
ried out using a polyphasic taxonomic approach, including 
chemotaxonomic, phenotypic, and genotypic characteristics 
(Anderson and Wellington 2001). Currently (Status April 
2020), about 841 species of the genus Streptomyces with 
valid names have been described and published so far (https 
://www.bacte rio.net/strep tomyc es.html). Thus, several stud-
ies have been conducted to find new strains isolated from 
extreme habitats (Tiwari and Gupta 2012; Goodfellow 2013; 
Zhang et al. 2016). To cope with the major health problem 
of antibiotic-resistant microorganisms, many laboratories 
have focused on the discovery of new bioactive molecules 
produced from new species belonging to this genus. In fact, 
whole-genome sequencing (wgs) have opened new poten-
tial for better exploitation of useful secondary metabolites 
produced by this genus (Harrison and Studholme 2014; Lee 
et al. 2018; Ward and Allenb 2018). This fundamental tech-
nology was supported by the use of new bioinformatics tools 
like antiSMASH, which adds several new features, including 
prediction of gene cluster (Blin et al. 2017).
In this study, the genome of a new strain Streptomyces 
tunisialbus DSM  105760T, which produces a broad spectrum 
of secondary metabolites with antibacterial and antifungal 
effects (Ayed et al. 2018), was sequenced. The genome 
sequence of S. tunisialbus was established to broaden the 
genomic basis for functional and comparative analyses 
focusing on secondary metabolite biosynthesis clusters of 
the strain.
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Materials and methods
The genomic DNA was extracted from a culture grown 
3  days in ISP2 medium (Shirling and Gottlieb 1966), 
using cetyltrimethylammonium bromide (CTAB)-based 
method (Hopwood 2000). The quality of the DNA was 
assessed by gel-electrophoresis, and its quantity was deter-
mined by a fluorescence-based method using the Quant-iT 
PicoGreen dsDNA kit (Invitrogen) and the Tecan Infinite 
200 Microplate Reader (Tecan Deutschland GmbH). For 
sequencing of the S. tunisialbus DSM  105760T genome, 
4  μg of purified DNA was used to generate a paired 
library (TruSeq DNA PCR-Free Library Prep Kit, Illu-
mina). The draft genome sequence of strain S. tunisial-
bus was established by sequencing on an Illumina MiSeq 
system. To assemble the obtained and processed reads, 
the GS de novo Assembler software version 2.8 (Roche, 
Mannheim, Germany) with default setting was applied 
as recently described (Yücel et al. 2017). Annotation of 
the draft genome was performed by applying the GenDB 
2.0 system (Meyer et al. 2003) and Prokka version 1.11 
(Seemann 2014). To identify clusters involved in second-
ary metabolite biosynthesis, the annotated genome was 
analyzed by applying antiSMASH 5.1.2 (Blin et al. 2017). 
Based on the 16S analysis in Ayed et al., S. varsoviensis 
NRRL ISP-5346 was determined as closest relative with 
a sequenced genome. S. varsoviensis NRRL ISP-5346 
was found to produce multiple hygrolide sub-families, 
e.g., hygrobafilomycins (JBIR-100 and hygrobafilomy-
cin) and bafilomycins (bafilomycins C1 and D) (Molloy 
et al. 2016). Finally, comparative genome analysis for S. 
tunisialbus DSM  105760T and S. varsoviensis NRRL ISP-
5346 was performed by means of the comparative genom-
ics tool EDGAR (Blom et al. 2009, 2016). To determine 
the relatedness between the S. tunisialbus DSM  105760T 
and S. varsoviensis NRRL ISP-5346 (Accession number: 
JOBF0100001-118), an average nucleotide identity anal-
ysis (ANI), average amino acid identity analysis (AAI) 
(Konstantinidis and Tiedje 2005) and a DDH estimation 
were performed as described previously (Meier-Kolthoff 
et al. 2013).
Results and discussion
The MiSeq sequencing run (2 × 300  bp) resulted in 
2,092,356 reads yielding approx. 627 Mb sequence infor-
mation for the sample representing on average a coverage of 
about 90-fold. The final draft genome established by the GS 
Assembler software (version 2.8, Roche) consists of 35 con-
tigs (N50: 455,831 bp) and 20 scaffolds (N50: 678,417 bp). 
The annotation of the draft genome of S. tunisialbus showed 
a linear chromosome which has a size of 6,880,753 bp and 
encodes 5802 protein-coding sequences (CDS)s. The chro-
mosome also contains 72 tRNA genes and eight rRNA oper-
ons (16S-23S-5S rRNA). The average GC content is 71.85% 
(Table 1).
An ANI value of 84.93%, an AAI value of 87.43% and 
a DDH value of 25.00% were calculated for S. tunisialbus 
DSM  105760T and S. varsoviensis NRRL ISP-5346. High 
ANI, AAI values (above 95%) and high DDH estimations 
(Formula 2 above 70%) were usually observed for bacterial 
isolates representing the same species and are considered to 
indicate bacterial species demarcation previously (Konstan-
tinidis and Tiedje 2005). Therefore, both strains are closely 
related, but do not belong to the same species.
By applying EDGAR, a comparative analysis was per-
formed for S. tunisialbus DSM  105760T and S. varsoviensis 
NRRL ISP-5346. It appeared that 3830 genes corresponding 
to 66% and 55% of all genes identified in both draft genomes 
represent the core set of genes shared by both isolates. These 
core genes mainly encode for housekeeping functions, e.g., 
glycolysis. However, S. tunisialbus DSM  105760T possesses 
1972 singletons, whereas 3062 singletons were identified for 
S. varsoviensis NRRL ISP-5346. Most of the S. tunisialbus 
DSM  105760T singletons were annotated as ‘hypothetical’ 
genes or transposases. However, genes encoding enzymes 
potentially involved in the synthesis of secondary metabo-
lites were identified within the unique genes of S. tunisialbus 
DSM  105760T. In addition, a few unique genes encoding for 
different cytochromes were found. For S. varsoviensis NRRL 
ISP-5346, the clusters found to produce hygrobafilomycins 
(JBIR-100 and hygrobafilomycin) and bafilomycins (bafilo-
mycins C1 and D) were unique.
Table 1  General features of S. 
tunisialbus DSM  105760T and 
S. varsoviensis NRRL ISP-5346
Features S. tunisialbus DSM  105760T S. varsoviensis NRRL ISP-5346
Length (bp) 6,880,753 8,588,807
Status Draft genome (35 contigs) Draft genome (118 contigs)
G + C content (%) 71.85 72.40
CDS 5802 7229
rRNAs operons 8 NA
tRNAs genes 72 68
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To identify all clusters involved in secondary metabo-
lite biosynthesis, the S. tunisialbus DSM  105760T genome 
was analyzed by means of antiSMASH 5.1.2. The platform 
revealed the presence of 34 predicted gene clusters encode 
for potential secondary metabolites, such as antibiotics, anti-
tumor compounds, fungicide, and lantibiotics. Likewise, six 
of these gene clusters are terpenes, such 2-methylisoborneol 
[100%] a volatile organic compound well known for its bio-
logical activity, two for melanin biosynthesis and one for 
Ectoine (Table 2). S. varsoviensis NRRL ISP-5346 has a 
similar portfolio of secondary metabolite clusters (Table 3).
The presence of a large number of cryptic secondary 
metabolite gene clusters in its genome, offers unsuspected 
potential for synthesizing bioactive compounds. In addi-
tion, our study shows that sequencing of new strains allows 
the discovery of new secondary metabolites relevant in 
ecology, biotechnology and medicine.
Table 2  Secondary metabolite 
cluster of S. tunisialbus DSM 
 105760T
Region Type Most similar known cluster
Region 1 NRPS-like,lassopeptide Citrulassin B 100.00%
Region 2 Terpene 2-Methylisoborneol 100.00%
Region 3 T2PKS, T1PKS, NRPS, terpene JBIR-76/JBIR-77 68.00%
Region 4 NRPS C-1027 7.00%
Region 5 Terpene Calicheamicin 2.00%
Region 6 Ectoine Ectoine 100.00%
Region 7 Lanthipeptide SapB 75.00%
Region 8 Linaridin Pentostatine/vidarabine 12.00%
Region 9 Melanin Melanin 28.00%
Region 10 Melanin Melanin 28.00%
Region 11 Terpene Aristeromycin 6.00%
Region 12 Lassopeptide Lagmysin 60.00%
Region 13 T3PKS Herboxidiene 5.00%
Region 14 T3PKS, ladderane Vazabitide A 28.00%
Region 15 Butyrolactone Griseoviridin/fijimycin A 8.00%
Region 16 T1PKS Elaiophylin 8.00%
Region 17 T1PKS Guadinomine 7.00%
Region 18 T1PKS, thiopeptide, LAP, NRPS-like, terpene, NRPS Aureothin 100.00%
Region 19 hglE-KS a201a 5.00%
Region 20 Terpene 2-Methylisoborneol 75.00%
Region 21 hglE-KS, T3PKS Alkylresorcinol 100.00%
Region 22 NRPS, T1PKS, terpene Althiomycin 100.00%
Region 23 Bacteriocin, NRPS Kirromycin 16.00%
Region 24 T1PKS, Terpene, bacteriocin Nystatin A1 63.00%
Region 25 NRPS Deimino-antipain 66.00%
Region 26 NRPS, terpene, T1PKS, transAT-PKS, PKS-like Netropsin 100.00%
Region 27 Siderophore Vibrioferrin 18.00%
Region 28 Terpene Asukamycin 4.00%
Region 29 Terpene Hopene 69.00%
Region 30 Indole AT2433-A1 14.00%
Region 31 Butyrolactone
Region 32 NRPS Bacillibactin 46.00%
Region 33 T1PKS, NRPS, ladderane, arylpolyene, NRPS-like Atratumycin 55.00%
Region 34 siderophore
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Table 3  Secondary metabolite cluster of S. varsoviensis NRRL ISP-5346
Region Type Most similar known cluster
Region 1 Terpene, T1PKS, NRPS-like, phosphonate, nucleo-
side, lanthipeptide
Phosphinothricintripeptide 17.00%
Region 2 NRPS-like, T1PKS Miharamycin A/miharamycin B 40.00%
Region 3 PKS-like A-201A 12.00%
Region 4 Terpene
Region 5 NRPS Isocomplestatin 50.00%
Region 6 Lanthipeptide AmfS 80.00%
Region 7 Lassopeptide Anantin B1/anantin B2 40.00%
Region 8 Furan, NRPS Ficellomycin 3.00%
Region 9 NRPS-like, NRPS Friulimicin A/friulimicin B/friulimicin C/friulimicin D 27.00%
Region 10 Amglyccycl
Region 11 NRPS Streptobactin 47.00%
Region 12 Amglyccycl Hygromycin A 51.00%
Region 13 Fused, NRPS-like, TfuA-related, NRPS, T1PKS Thiovarsolin A/thiovarsolin B/thiovarsolin C/thiovarsolin D 83.00%
Region 14 NRPS rimosamide 42.00%
Region 15 T2PKS,PKS-like, oligosaccharide, LAP Dutomycin 36.00%
Region 16 Bacteriocin
Region 17 Terpene
Region 18 hglE-KS, T1PKS Tetronasin 9.00%
Region 19 Lanthipeptide
Region 20 Ectoine Ectoine 100.00%
Region 21 NRPS, T2PKS Kosinostatin 6.00%
Region 22 LAP, thiopeptide Jomthonic acid A/jomthonic acid B/jomthonic acid C 5.00%
Region 23 Thiopeptide, LAP
Region 24 Terpene Ansamitocin P-3 4.00%
Region 25 NRPS,CDPS Purincyclamide 100.00%
Region 26 T1PKS Chlorizidine A 57.00%
Region 27 Lanthipeptide
Region 28 NRPS, T3PKS Feglymycin 42.00%
Region 29 T1PKS, NRPS, aminocoumarin Bafilomycin B1 83.00%
Region 30 CDPS
Region 31 Terpene Ebelactone 5.00%
Region 32 Siderophore
Region 33 Siderophore Ficellomycin 3.00%
Region 34 Siderophore
Region 35 Terpene Hopene 61.00%
Region 36 Bacteriocin
Region 37 NRPS
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